How estrogen, progesterone, and testosterone shift in perimenopause

Three hormones, three different curves — and one window that lasts longer than most women are told.

TL;DR

• Perimenopause is not a single drop. It is three different curves moving at different speeds.
• Progesterone usually falls first, estrogen swings before it drops, and testosterone drifts gradually downward.
• The window typically runs 4 to 8 years before the final period, and it explains a lot of midlife symptoms that often get blamed elsewhere.

What it is

Perimenopause (in plain English: the years leading up to a woman’s last menstrual period) is the multi-year transition during which the ovaries slowly wind down their reproductive output. It is not menopause — that label only applies after 12 months without a period (Harlow et al., J Clin Endocrinol Metab, 2012).

How it works

Picture a thermostat that used to keep a steady temperature. In perimenopause, the dial gets less reliable. Some weeks the room is warmer than usual. Other weeks it overshoots cold. The signal is the brain-ovary feedback loop, and the swings happen because the ovaries respond less consistently to the brain’s monthly request.

Three hormones move during that window. Progesterone — the calming, cycle-balancing hormone — usually falls earliest, often in the late thirties or forties. Estrogen rides a roller coaster: it can swing higher than baseline before it eventually drops. Testosterone, which most women have at lower levels than men but in meaningful amounts, drifts downward gradually.

Who asks about it

The search usually starts with a symptom: a sudden mood change, sleep that no longer holds, periods that get unpredictable, or a libido shift in the early forties. The shared question is: is this hormones, and which ones?

What the research says

The largest longitudinal study of midlife women, the Study of Women’s Health Across the Nation (SWAN), describes a typical perimenopause window of about 4 to 8 years before the final period, with FSH (in plain English: a brain hormone that signals the ovary to release an egg) gradually rising as ovarian response declines (El Khoudary et al., Menopause, 2019). Estrogen variability — not a clean drop — is the strongest driver of many symptoms.

What to know before considering it

A baseline lab panel during perimenopause is usually a snapshot, not a verdict — hormone levels swing by the week. A clinician evaluation matters more than any single number. Treatment options range from lifestyle to hormone therapy and require an individual conversation.

The Halftime POV

Half of midlife is perimenopause for women. We do not think that should be a guessing game. The science is clear, the language often is not, and that gap is a place we can be useful.

Related reading:

• Sermorelin: women, growth hormone decline, and what changes
• IGF-1 lab reference ranges: what an optimal level looks like by age
• GHK-Cu research: what the dermatology literature shows

FAQ

Q: What hormones change in perimenopause? A: The three big shifts are estrogen, progesterone, and testosterone. Progesterone usually falls first, in the late thirties or forties. Estrogen swings up and down before it eventually drops. Testosterone drifts gradually downward across the same window.

Q: When does perimenopause typically start? A: Perimenopause usually starts in the early to mid-forties, but it can begin in the late thirties. Most women are in it for about 4 to 8 years before their final period.

Q: Are these shifts the same for everyone? A: No. Genetics, body composition, stress, sleep, and underlying health all influence the timing and the symptoms. Two women the same age can be in very different parts of the transition.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. We’ll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we’ll email you when we’re live.

Sources

• El Khoudary SR, et al. The menopause transition and women’s health at midlife. Menopause, 2019.
• Harlow SD, et al. Executive summary of the Stages of Reproductive Aging Workshop +10. J Clin Endocrinol Metab, 2012.